Home › Small Cell Lung Cancer › Michigan › Detroit
Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Detroit, MI
Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Detroit. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Nagre-recruitPhase 2
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Nagre-recruitPhase 1/2
- Barbara Ann Karmanos Cancer Center, Detroit
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Nagre-recruitPhase 1/2
- Karmanos Cancer Institute, Detroit
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Nagre-recruitPhase 3
- Henry Ford Health Cancer, Detroit
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Nagre-recruitPhase 1
- Henry Ford Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Karmanos Cancer Institute, Detroit
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Nagre-recruitPhase 3
- Henry Ford Health System, Detroit
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Nagre-recruitPhase 2
- Henry Ford Cancer- Detroit, Detroit
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
Nagre-recruitPhase 2
- Karmanos Cancer Center (Wayne State University), Detroit
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Nagre-recruitPhase 2
- Henry Ford Health Saint John Hospital, Detroit
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Henry Ford Health System, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 129, Detroit
Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod
- Houston, TX26 pag-aaral
- Arlington, VA23 pag-aaral
- New York City, NY22 pag-aaral
- Boston, MA21 pag-aaral
- Nashville, TN20 pag-aaral
- Los Angeles, CA20 pag-aaral
- Orlando, FL15 pag-aaral
- Dallas, TX13 pag-aaral
- Cleveland, OH13 pag-aaral
- Chicago, IL13 pag-aaral
- St. Louis, MO13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Detroit
- Non-Small Cell Lung Cancer44 pag-aaral
- Kanser sa Suso33 pag-aaral
- Kanser (lahat ng uri)29 pag-aaral
- Colorectal Cancer26 pag-aaral
- Kanser sa Ovary26 pag-aaral
- Metastatic Cancer24 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser ng Endometrium21 pag-aaral
- Kanser sa Baga20 pag-aaral
- Multiple Myeloma19 pag-aaral
- Kanser sa Tiyan16 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.